Tf. Ismail et al., EVALUATION OF ANTIBODIES REACTIVE WITH CAMPYLOBACTER-JEJUNI IN EGYPTIAN DIARRHEA PATIENTS, Clinical and diagnostic laboratory immunology, 4(5), 1997, pp. 536-539
Serum and stool samples were collected from 128 individuals: 96 diarrh
ea patients and 32 apparently healthy controls. Stool specimens were c
ultured for enteric bacterial pathogens, while sera were screened by e
nzyme-linked immunosorbent assay for Campylobacter jejuni-reactive ant
ibodies. Of 28 diarrhea patients who demonstrated C. jejuni-reactive a
ntibodies (titers, > 100), 14 were culture positive for this organism.
The 32 healthy controls showed significantly lower antibody titers (P
< 0.05) with the exception of 10 subjects who were culture positive f
or C. jejuni and had reactive immunoglobulin M (IgM) (6 subjects) and
IgG (7 subjects). IgA was not detected in those 10 individuals (asympt
omatic). Avidity was expressed as the thiocyanate ion concentration re
quired to inhibit 50% of the bound antibodies, The avidity was higher
in symptomatic patients than asymptomatic healthy controls. IgG was le
ss avid (0.92 M) compared to IgM (0.1 M) and IgA (1.1 M), with no corr
elation between antibody titer and avidity, However, the thiocyanate i
on concentration required for the complete inhibition of IgG (5 M)-bou
nd antibodies was higher than that of IgA (2 M) and IgM (3 M), This st
udy also shows that C. jejuni antibodies were variably cross-reactive
with Escherichia coli, Shigella flexneri, Shigella sonnei, and Neisser
ia meningitidis in addition to Campylobacter coli and Campylobacter re
ctus.